Trial Site Detail

 

Drug:
Imatinib
Trial:
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Institut Paoli-Calmette

     
Marseille , Bouches du Rhone 13273
France

 

Principal Investigator:
 François Bertucci, Pr
Contact:
 François BERTUCCI, Pr +33 4 91 22 35 37 bertuccif@ipc.unicancer.fr
Activation Status of this Site:
 Not yet activated
Notes about this Site:
Institut Paoli-Calmette Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.